Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.320 | 9 | 21984662 | intron variant | A/C;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.050 | 1.000 | 5 | 2010 | 2018 | ||||||||
|
1.000 | 0.120 | 9 | 21968347 | intron variant | T/C | snv | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 4 | 2001 | 2012 | |||||||
|
0.763 | 0.320 | 9 | 21984662 | intron variant | A/C;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.030 | 1.000 | 3 | 2010 | 2018 | ||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||||
|
0.763 | 0.320 | 9 | 21984662 | intron variant | A/C;T | snv |
|
0.020 | 1.000 | 2 | 2017 | 2018 | |||||||||
|
0.763 | 0.320 | 9 | 21984662 | intron variant | A/C;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 2 | 2013 | 2018 | ||||||||
|
0.763 | 0.240 | 9 | 21974219 | intron variant | A/G | snv | 0.26 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2008 | 2014 | |||||||
|
0.763 | 0.240 | 9 | 21974219 | intron variant | A/G | snv | 0.26 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.763 | 0.240 | 9 | 21974219 | intron variant | A/G | snv | 0.26 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2008 | 2014 | |||||||
|
9 | 21990458 | intron variant | C/T | snv | 0.74 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||||
|
0.925 | 0.080 | 9 | 21978980 | intron variant | C/T | snv | 0.43 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 9 | 21978980 | intron variant | C/T | snv | 0.43 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.120 | 9 | 21980152 | intron variant | A/G | snv | 0.88 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.160 | 9 | 21991924 | intron variant | C/T | snv | 0.47 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
9 | 21989331 | intron variant | T/C | snv | 2.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
9 | 21989331 | intron variant | T/C | snv | 2.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 9 | 21988897 | intron variant | C/T | snv | 0.86 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.080 | 9 | 21988897 | intron variant | C/T | snv | 0.86 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
9 | 21986848 | intron variant | T/A | snv | 0.74 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
9 | 21985772 | intron variant | A/G | snv | 1.2E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |